1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. ARS PHARMACEUTICALS INC
ARS Pharmaceuticals Inc XNAS: SPRY

ARS Pharma Inc Live Stock Price Today, Share Analysis and Chart

Expensive Performer
about

ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the development of novel, potentially first-in-class product candidate, neffy for the emergency treatment of Type I allergic reactions, including anaphylaxis. neffy is a proprietary co...

Read More
10.21 -0.36 (-3.41%)
45.98% Fall from 52W High
1.5M
XNAS Volume

XNAS 23 Jan, 2026 4:30 PM (EST)

Watchlist

Portfolio

Alert
Durability score
Medium Financial Strength
44.4 / 100
Valuation Score
Expensive Valuation
14.7 / 100
Momentum Score
Technically Neutral
40.7 / 100
Expensive Performer These stocks have medium quality and momentum.Their expensive valuations suggest caution View Similar Embed DVM
Analyst Price Target
28
1Yr Price target upside is 174%
6 analysts

8

S

7

W

3

O

2

T

SWOT Analysis

ARS Pharma Inc Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..